Modern glaucoma management extends far beyond lowering intraocular pressure. In two clinically focused webinars, Dr. Mitch Ibach and Dr. Jessica Steen explore complementary aspects of contemporary care—from evidence-based treatment strategies for open- and closed-angle glaucoma, including SLT, MIGS, and drug delivery systems, to the critical role of individualized risk assessment in patients with complex ocular and systemic comorbidities. Together, these sessions highlight the importance of gonioscopy, adherence-focused therapies, and careful interpretation of imaging in the presence of retinal disease, high myopia, and ocular surface disease. The result is a comprehensive framework for optimizing long-term glaucoma outcomes through both targeted treatment and holistic patient care.

From keratoconus management and blinking mechanics to aesthetics in optometry and neural vision training, today’s advances are redefining how clinicians approach eye care. Each topic offers new ways to combine science, empathy, and innovation — ultimately improving not just how patients see, but how they live.

The CLOSE (Collaborative Learning in Ocular Surface Education) program is designed for a wide range of eye care professionals who are passionate about advancing their knowledge and skills in diagnosing and managing ocular surface disease.  By participating in CLOSE, practitioners at all levels can enhance patient outcomes, stay ahead of emerging trends, and transform the way they manage dry eye disease and ocular surface conditions.

Dry Eye Disease (DED) affects over 30 million people in North America alone, with more than 42% of patients showing symptoms. This highlights a substantial demand for eye care practitioners skilled in diagnosing and managing DED. Symptoms include persistent eye redness, a gritty sensation, intermittent blurred vision, and constant eye dryness or discomfort. Untreated DED can significantly impact daily activities and quality of life. It frequently coexists with conditions like allergies, diabetes, glaucoma, and among contact lens wearers.